Your session is about to expire
← Back to Search
Social Media-Based Parenting Program for Postpartum Depression
N/A
Waitlist Available
Led By James Guevara, MD,MPH
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Women who screen positive for postpartum depression (score>9) on the EPDS at a participating pediatric practice
Children <8 months old
Must not have
Children who were born premature (estimated gestational age<35 weeks)
Children who are already currently receiving early intervention services for developmental delays at baseline
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a parenting program combined with online depression treatment leads to more responsive parenting and improved child development compared to depression treatment alone.
Who is the study for?
This trial is for English-speaking women over 18 years old with infants less than 8 months of age, who have internet access and a smartphone or tablet. They must show signs of postpartum depression as indicated by scoring more than 9 on the EPDS.
What is being tested?
The study tests if a social media-based parenting program combined with an online depression treatment (MoodGym) can improve parenting responsiveness and benefit child language, socioemotional, and cognitive development compared to just treating depression alone.
What are the potential side effects?
Since this trial involves non-medical interventions like a social media-based program and online therapy, typical medical side effects are not expected. However, participants may experience emotional discomfort or stress.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I scored over 9 on the EPDS, indicating postpartum depression.
Select...
My child is younger than 8 months old.
Select...
I have an infant who is less than 8 months old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I was born before 35 weeks of pregnancy.
Select...
My child is already getting help for developmental delays.
Select...
My child has a condition that could delay their development.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in parent-child interactions
Secondary study objectives
Acceptability of the online depression treatment program
Acceptability of the parenting program
Changes in parenting competence
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Parenting Program + MoodGymExperimental Treatment2 Interventions
The social media-based parenting program consists of 8 weekly sessions using a Facebook platform with the following topics: depression psychoeducation and behavioral activation, infant temperament, play, feeding, safety, sleep, parent-child interactions, and shared book reading. Participants in the experimental arm will also be enrolled in the online depression treatment program, MoodGym.
Group II: MoodGym AloneActive Control1 Intervention
The MoodGym program is an evidence-based online cognitive behavioral treatment program that has been shown to be effective at reducing depression symptoms in a meta-analysis of 11 trials (g=0.36, 95% CI 0.17-0.56). Moodgym contains five modules with interactive exercises, workbooks, anxiety and depression quizzes, and downloadable relaxation audio files that can be completed online without therapist interaction.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social Media-Based Parenting Program
2019
N/A
~80
MoodGym
2019
N/A
~120
Find a Location
Who is running the clinical trial?
Children's Hospital of PhiladelphiaLead Sponsor
731 Previous Clinical Trials
8,472,224 Total Patients Enrolled
5 Trials studying Parenting
404 Patients Enrolled for Parenting
National Institute of Mental Health (NIMH)NIH
2,936 Previous Clinical Trials
2,751,546 Total Patients Enrolled
7 Trials studying Parenting
1,025 Patients Enrolled for Parenting
James Guevara, MD,MPHPrincipal InvestigatorChildren's Hospital of Philadelphia
Rhonda Boyd, PhDPrincipal InvestigatorChildren's Hospital of Philadelphia
4 Previous Clinical Trials
212 Total Patients Enrolled
1 Trials studying Parenting
75 Patients Enrolled for Parenting
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You must be able to read and speak English.You can participate if you have a smartphone or tablet with internet access.I am a woman older than 18.I am a woman who can speak and read English.I was born before 35 weeks of pregnancy.I scored over 9 on the EPDS, indicating postpartum depression.My child is already getting help for developmental delays.My child has a condition that could delay their development.My child is younger than 8 months old.I have an infant who is less than 8 months old.I am older than 18 years.I have a baby who is younger than 8 months.I am under 8 months old.You have been screened for postpartum depression at a pediatric clinic, and your score on the EPDS (Edinburgh Postnatal Depression Scale) is higher than 9.
Research Study Groups:
This trial has the following groups:- Group 1: Parenting Program + MoodGym
- Group 2: MoodGym Alone
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.